Mendoza PN, Figueroa HJL

Language: Spanish
References: 18
Page: 252-255
PDF size: 43.08 Kb.

Text Extraction

No abstract

REFERENCES

1. Meyers FH, Jawetz E, Goldfien A. Farmacología Clínica. 4ª Ed. Manual Moderno Ed. México, 1980.

2. Goth A. Farmacología Médica. 9ª Ed. Mosby Co. Eds.España, 1979.

3. Hardman JG, Limbird LE, Molinoff PB et al. Goodman & Gillman. The pharmacological basis of therapeutics. 10th Ed. Mc. Graw-Hill Interamericana, New York, 2001.

4. Luna AB. Capítulo 50 antileprosos. En: Farmacología Clínica. Eds. Uriarte Bonilla y Flores Caso ST. Ed. Trillas. México, 2003.

5. Mendoza PN, Figueroa-Hernández JL, de León JA. Perspectivas del uso clínico de la aspirina. Revista Facultad de Medicina UNAM 2004; 47(5): 211-212.

6. McCombs J. Treatment of preeclampsia and eclampsia. Clinical Pharmacy 1992; 11(3): 236-245.

7. Bernheim J. Hypertension in pregnancy. Nephron 1997; 76(3): 254-263.

8. Sungai FC, Malata A, Masanhika R. Preeclampsia/eclampsia: a literature review. Central African Journal of Medicine 1998; 44(10): 261-3.

9. Niittyvuopio R, Juvonen E, Kaaja R, Oksaken K, Hallman H, Timonen T, Ruutu T. Pregnancy in essential thrombocythaemia: experience with 40 pregnancies. European Journal of Haematology. 2004; 73(6): 431-6.

10. Diccionario terminológico de ciencias médicas. 12 Ed. Salvat México, 1987.

11. Ment LR, Oh W, Ehrenkranz RA, Philip, AG, Vohr B, Allan W, Duncan CC et al. Low-dose indomethacin and prevention of intraventricular hemorrhage: a multicenter randomized trial. Pediatrics 1994; 93: 543-550.

12. Mejía JS. Tesis: efecto neuroprotector de los antioxidantes en un modelo de izquemia cerebral aguda. Julio 2005.

13. Barranco VP. Inhibition of lysosomal enzymes by dapsone. Arch Dermatol 1974; 110: 563.

14. Maloff BL. Dapsone inhibits LTB4 binding and bioresponse at the cellular and physiologic levels. Eur J Pharmacol 1998; 158: 85.

15. Jiménez-Orozco A, Molina-Guarneros JA, Mendoza-Patiño N, León-Cedeño F, Flores-Pérez B, Santos-Santos E, Mandoki JJ. Cytostatic activity of coumarin metabolites and derivaties in the B16-F10 murine melanoma cell line. Melanoma Research 1999; 9: 243-247.

16. Stoof JC, Booij J, Drukarch B. Amantadine as N-methyl-D-aspartic acid Receptor antagonist: New possibilities for therapeutic applications? Clin Neurolog Neurosurg 1992; 94(Suppl.): S4-S6.

17. http://www.nlm.nih.gov./medlineplus/print/druginfo/uspdi/203662.html

18. PLM, Diccionario de especialidades farmacéuticas. Dextrazoxano: Información para prescribir amplia, por Laboratorio ASOFARMA de México, SA de CV, 2006.